Results
Suven Life Sciences Reports ₹548.6 Crore FY26 Loss, Advances Clinical Pipeline
Suven Life Sciences reported a standalone net loss of ₹548.63 crore for FY26 while raising ₹764.33 crore through preferential warrants to fund clinical development programs.
The company advanced five
